Latest Trials Latest NewsFAQ

University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Biosynthesis of PGD2 in Vivo

Not Applicable

Completed

Conditions: Hyperlipidemia

Interventions: Drug: Placebo
Drug: Aspirin
Drug: Niacin

First Posted Date: 2011-01-12

Last Posted Date: 2021-06-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 9

Registration Number: NCT01275300

Locations: 🇺🇸
University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

Phase 4

Terminated

Conditions: Complex Partial Seizures

Interventions: Drug: vigabatrin

First Posted Date: 2010-12-24

Last Posted Date: 2017-07-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1

Registration Number: NCT01266291

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Modulation of Monocyte Activation by Atorvastatin in HIV Infection

Phase 4

Completed

Conditions: HIV Dementia

Interventions: Drug: Atorvastatin

First Posted Date: 2010-12-21

Last Posted Date: 2019-05-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 5

Registration Number: NCT01263938

Locations: 🇺🇸
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States

Pudendal Assessment in Erectile Dysfunction

Terminated

Conditions: Erectile Dysfunction

First Posted Date: 2010-12-17

Last Posted Date: 2014-03-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT01262833

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals

Phase 4

Completed

Conditions: HIV Infection

Interventions: Biological: Fluzone®

First Posted Date: 2010-12-17

Last Posted Date: 2017-04-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 195

Registration Number: NCT01262846

Locations: 🇺🇸
Clinical Trials Unit. University of Pennsylvania, Philadelphia, Pennsylvania, United States

An In-Hospital Family Member Cardiopulmonary Resuscitation (CPR) Education Program

Phase 1

Completed

Conditions: Coronary Disease
Cardiac Arrest
Cardiovascular Risk Factors

Interventions: Other: CPR Training using the Family and Friends CPR Anytime VSI Kit

First Posted Date: 2010-12-15

Last Posted Date: 2018-11-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 500

Registration Number: NCT01260441

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸
Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

Cognitive Training for Nicotine Dependence

Not Applicable

Completed

Conditions: Tobacco Use Disorder
Nicotine Addiction

Interventions: Behavioral: Control training
Behavioral: Cognitive Training

First Posted Date: 2010-12-03

Last Posted Date: 2017-01-16

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 213

Registration Number: NCT01252966

Locations: 🇺🇸
Center for Interdiscplinary Research on Nicotine Addiction, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Cardiopulmonary Resuscitation (CPR) Dissemination Study Using Nurses and Volunteers

Phase 1

Completed

Conditions: Cardiovascular Risk Factors
Coronary Disease
Cardiac Arrest

Interventions: Other: CPR Training using the Family and Friends CPR Anytime VSI Kit
Other: Implementation of an In-Hospital CPR Training Model

First Posted Date: 2010-12-02

Last Posted Date: 2018-11-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 500

Registration Number: NCT01252316

Locations: 🇺🇸
Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis

Not Applicable

Completed

Conditions: Dyslipidemias

Interventions: Other: Placebo
Drug: Niacin

First Posted Date: 2010-12-01

Last Posted Date: 2016-07-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 22

Registration Number: NCT01250990

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

Phase 2

Completed

Conditions: Myeloma

Interventions: Biological: Prevnar- Pneumococcal Conjugate Vaccine (PCV)
Other: Activated/costimulated autologous T-cell
Drug: Revlamid® (Lenalidomide)
Biological: MAGE-A3/GM-GSF, Hiltonol® (Poly-ICLC)

First Posted Date: 2010-11-22

Last Posted Date: 2020-04-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 28

Registration Number: NCT01245673

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy